{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:33:39Z","timestamp":1792712019213,"version":"4.5.0"},"reference-count":95,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cushing syndrome results from supraphysiological exposure to glucocorticoids and is associated with significant morbidity and mortality. The pathogenesis includes administration of corticosteroids (exogenous Cushing syndrome) or autonomous cortisol overproduction, whether or not ACTH-dependent (endogenous Cushing syndrome). An early diagnosis of Cushing syndrome is warranted; however, in clinical practice, it is very challenging partly because of resemblance with other common conditions (ie, pseudo-Cushing syndrome). Initial workup should start with excluding local and systemic corticosteroid use. First-line screening tests including the 1-mg dexamethasone suppression test, 24-hour urinary free cortisol excretion, and late-night salivary cortisol measurement should be performed to screen for endogenous Cushing syndrome. Scalp-hair cortisol\/cortisone analysis helps in the assessment of long-term glucocorticoid exposure as well as in detection of transient periods of hypercortisolism as observed in cyclical Cushing syndrome. Interpretation of results can be difficult because of individual patient characteristics and hence requires awareness of test limitations. Once endogenous Cushing syndrome is established, measurement of plasma ACTH concentrations differentiates between ACTH-dependent (80%-85%) or ACTH-independent (15%-20%) causes. Further assessment with different imaging modalities and dynamic biochemical testing including bilateral inferior petrosal sinus sampling helps further pinpoint the cause of Cushing\u2019s syndrome. In this issue of \u201cApproach to the patient,\u201d the diagnostic workup of Cushing syndrome is discussed with answering the questions when to screen, how to screen, and how to differentiate the different causes. In this respect, the latest developments in biochemical and imaging techniques are discussed as well.<\/jats:p>","DOI":"10.1210\/clinem\/dgac492","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T11:37:55Z","timestamp":1661773075000},"page":"3162-3174","source":"Crossref","is-referenced-by-count":87,"title":["Approach to the Patient: Diagnosis of Cushing Syndrome"],"prefix":"10.1210","volume":"107","author":[{"given":"Mesut","family":"Savas","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Mehta","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, NYU Langone Medical Center\/ Bellevue Hospital Center , New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, NYU Langone Medical Center\/ Bellevue Hospital Center , New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0120-4913","authenticated-orcid":false,"given":"Elisabeth F C","family":"van Rossum","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Feelders","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"2022122606511267100_CIT0001","first-page":"185","volume-title":"The Human Hypothalamus","author":"Agrawal","year":"2021"},{"issue":"9996","key":"2022122606511267100_CIT0002","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"2022122606511267100_CIT0003","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022122606511267100_CIT0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ecl.2007.10.010","article-title":"Cushing\u2019s syndrome","volume":"37","author":"Pivonello","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2022122606511267100_CIT0005","first-page":"281","article-title":"Cushing\u2019s syndrome: epidemiology and developments in disease management","volume":"7","author":"Sharma","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2022122606511267100_CIT0006","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fendo.2019.00862","article-title":"Quality of life in patients with Cushing\u2019s disease","volume":"10","author":"Santos","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 1","key":"2022122606511267100_CIT0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000315813","article-title":"Mortality in Cushing\u2019s disease","volume":"92","author":"Clayton","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"6","key":"2022122606511267100_CIT0008","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022122606511267100_CIT0009","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2022122606511267100_CIT0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/gs.2019.11.03","article-title":"Cardiovascular risk and mortality in patients with active and treated hypercortisolism","volume":"9","author":"Li","year":"2020","journal-title":"Gland Surg"},{"issue":"5","key":"2022122606511267100_CIT0011","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing\u2019s syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2022122606511267100_CIT0012","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1590\/S0004-27302007000800025","article-title":"Cushing\u2019s syndrome: aftermath of the cure","volume":"51","author":"Pivonello","year":"2007","journal-title":"Arq Bras Endocrinol Metabol."},{"issue":"2","key":"2022122606511267100_CIT0013","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","article-title":"The metabolic syndrome and cardiovascular risk in Cushing\u2019s syndrome","volume":"34","author":"Pivonello","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"2022122606511267100_CIT0014","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11102-015-0645-6","article-title":"Comorbidities in Cushing\u2019s disease","volume":"18","author":"Sharma","year":"2015","journal-title":"Pituitary"},{"issue":"2","key":"2022122606511267100_CIT0015","doi-asserted-by":"crossref","first-page":"bvz033","DOI":"10.1210\/jendso\/bvz033","article-title":"Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study","volume":"4","author":"Suarez","year":"2020","journal-title":"J Endocr Soc."},{"issue":"9","key":"2022122606511267100_CIT0016","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","article-title":"The immune system in Cushing\u2019s syndrome","volume":"31","author":"Hasenmajer","year":"2020","journal-title":"Trends Endocrinol Metab."},{"issue":"7","key":"2022122606511267100_CIT0017","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"2022122606511267100_CIT0018","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"Suppl 1","key":"2022122606511267100_CIT0019","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000314213","article-title":"Pathophysiology of dyslipidemia in Cushing\u2019s syndrome","volume":"92","author":"Arnaldi","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"Suppl 1","key":"2022122606511267100_CIT0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000314319","article-title":"Pathophysiology of diabetes mellitus in Cushing\u2019s syndrome","volume":"92","author":"Pivonello","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2022122606511267100_CIT0021","doi-asserted-by":"crossref","first-page":"101380","DOI":"10.1016\/j.beem.2020.101380","article-title":"Cushing\u2019s syndrome: overview of clinical presentation, diagnostic tools and complications","volume":"34","author":"Barbot","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"15","key":"2022122606511267100_CIT0022","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","article-title":"Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events","volume":"74","author":"Fardet","year":"2014","journal-title":"Drugs."},{"issue":"4","key":"2022122606511267100_CIT0023","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbi.2004.11.004","article-title":"Chronic stress and comfort foods: self-medication and abdominal obesity","volume":"19","author":"Dallman","year":"2005","journal-title":"Brain Behav Immun."},{"issue":"4","key":"2022122606511267100_CIT0024","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12094","article-title":"Hypercoagulability in Cushing\u2019s syndrome: prevalence, pathogenesis and treatment","volume":"78","author":"van der Pas","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2022122606511267100_CIT0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11102-012-0394-8","article-title":"Clinical consequences of Cushing\u2019s syndrome","volume":"15","author":"Valassi","year":"2012","journal-title":"Pituitary"},{"issue":"Suppl 1","key":"2022122606511267100_CIT0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314317","article-title":"Neuropsychiatric disorders in Cushing\u2019s syndrome","volume":"92","author":"Pereira","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2022122606511267100_CIT0027","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing\u2019s disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev."},{"issue":"5","key":"2022122606511267100_CIT0028","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/jc.2002-021494","article-title":"Nephrolithiasis in Cushing\u2019s disease: prevalence, etiopathogenesis, and modification after disease cure","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022122606511267100_CIT0029","first-page":"5325","article-title":"Improvement but no normalization of quality of life and cognitive functioning after treatment of Cushing syndrome","volume":"104","author":"Broersen","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022122606511267100_CIT0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacol Ther."},{"issue":"10","key":"2022122606511267100_CIT0031","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1210\/jc.2018-00352","article-title":"Glucocorticoid receptor mutations and hypersensitivity to endogenous and exogenous glucocorticoids","volume":"103","author":"Santen","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022122606511267100_CIT0032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids","volume":"44","author":"Czock","year":"2005","journal-title":"Clin Pharmacokinet."},{"issue":"2","key":"2022122606511267100_CIT0033","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1523-1755.2004.00772.x","article-title":"Antiretroviral and immunosuppressive drug-drug interactions: an update","volume":"66","author":"Izzedine","year":"2004","journal-title":"Kidney Int."},{"issue":"3","key":"2022122606511267100_CIT0034","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"7","key":"2022122606511267100_CIT0035","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"2022122606511267100_CIT0036","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022122606511267100_CIT0037","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1210\/jc.2017-01133","article-title":"Associations between systemic and local corticosteroid use with metabolic syndrome and body mass index","volume":"102","author":"Savas","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"3-4","key":"2022122606511267100_CIT0038","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000501617","article-title":"Systemic and local corticosteroid use is associated with reduced executive cognition, and mood and anxiety disorders","volume":"110","author":"Savas","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"11","key":"2022122606511267100_CIT0039","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1159\/000513703","article-title":"Anthropometrics and metabolic syndrome in relation to glucocorticoid receptor polymorphisms in corticosteroid users","volume":"111","author":"Savas","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2022122606511267100_CIT0040","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EC-19-0435","article-title":"Approach to patients with pseudo-Cushing\u2019s states","volume":"9","author":"Scaroni","year":"2020","journal-title":"Endocr Connect"},{"issue":"8299","key":"2022122606511267100_CIT0041","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(82)92749-0","article-title":"Cushing\u2019s syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis","volume":"2","author":"Ross","year":"1982","journal-title":"Lancet"},{"issue":"1","key":"2022122606511267100_CIT0042","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2265.2012.04488.x","article-title":"Discriminatory value of signs and symptoms in Cushing\u2019s syndrome revisited: what has changed in 30 years?","volume":"78","author":"Schneider","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2022122606511267100_CIT0043","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an Endocrine Society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022122606511267100_CIT0044","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-14-0599","article-title":"Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma","volume":"172","author":"Toini","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2022122606511267100_CIT0045","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in Cushing\u2019s syndrome: a systematic review","volume":"94","author":"Van Zaane","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022122606511267100_CIT0046","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with Cushing\u2019s syndrome: a multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022122606511267100_CIT0047","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1210\/jc.2008-0139","article-title":"Accuracy of diagnostic tests for Cushing\u2019s syndrome: a systematic review and metaanalyses","volume":"93","author":"Elamin","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022122606511267100_CIT0048","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000498886","article-title":"Hair glucocorticoids as a biomarker for endogenous Cushing\u2019s syndrome: validation in two independent cohorts","volume":"109","author":"Savas","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2022122606511267100_CIT0049","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1210\/jc.2005-2212","article-title":"Strategies for the characterization of disorders in cortisol sensitivity","volume":"91","author":"Russcher","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022122606511267100_CIT0050","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrendo.2013.183","article-title":"Glucocorticoid sensitivity in health and disease","volume":"9","author":"Quax","year":"2013","journal-title":"Nat Rev Endocrinol."},{"issue":"5","key":"2022122606511267100_CIT0051","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jc.2008-0040","article-title":"Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder","volume":"93","author":"Charmandari","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"2022122606511267100_CIT0052","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000321234","article-title":"Glucocorticoid resistance","volume":"20","author":"van Rossum","year":"2011","journal-title":"Endocr Dev."},{"issue":"4","key":"2022122606511267100_CIT0053","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2265.1982.tb00733.x","article-title":"Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone","volume":"16","author":"Meikle","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2022122606511267100_CIT0054","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0004563219870834","article-title":"Retrospective analysis of repeated dexamethasone suppression tests - the added value of measuring dexamethasone","volume":"56","author":"de Graaf","year":"2019","journal-title":"Ann Clin Biochem."},{"issue":"3","key":"2022122606511267100_CIT0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tox.2011.04.007","article-title":"Environmental inhibitors of 11beta-hydroxysteroid dehydrogenase type 2","volume":"285","author":"Ma","year":"2011","journal-title":"Toxicology"},{"issue":"5","key":"2022122606511267100_CIT0056","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-16-0946","article-title":"Diagnosis of endocrine disease: differentiation of pathologic\/neoplastic hypercortisolism (Cushing\u2019s syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing\u2019s syndrome)","volume":"176","author":"Findling","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2022122606511267100_CIT0057","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-13-0702","article-title":"Differentiating between Cushing\u2019s disease and pseudo-Cushing\u2019s syndrome: comparison of four tests","volume":"170","author":"Alwani","year":"2014","journal-title":"Eur J Endocrinol."},{"issue":"17","key":"2022122606511267100_CIT0058","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.1993.03500170062035","article-title":"Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing\u2019s syndrome from pseudo-Cushing\u2019s states","volume":"269","author":"Yanovski","year":"1993","journal-title":"JAMA"},{"issue":"10","key":"2022122606511267100_CIT0059","doi-asserted-by":"crossref","first-page":"E1836","DOI":"10.1210\/jc.2012-1852","article-title":"A novel tool in the diagnosis and follow-up of (cyclic) Cushing\u2019s syndrome: measurement of long-term cortisol in scalp hair","volume":"97","author":"Manenschijn","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022122606511267100_CIT0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/eem.11.95","article-title":"Measuring cortisol levels in hair: potential clinical applications in Cushing\u2019s syndrome","volume":"7","author":"van Rossum","year":"2012","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"6","key":"2022122606511267100_CIT0061","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-16-0873","article-title":"Scalp hair cortisol for diagnosis of Cushing\u2019s syndrome","volume":"176","author":"Wester","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2022122606511267100_CIT0062","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/17446651.2018.1517043","article-title":"Mini-review of hair cortisol concentration for evaluation of Cushing syndrome","volume":"13","author":"Hodes","year":"2018","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"2","key":"2022122606511267100_CIT0063","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cen.12781","article-title":"LC-MS\/MS-based method for long-term steroid profiling in human scalp hair","volume":"83","author":"Noppe","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022122606511267100_CIT0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2018.09.010","article-title":"Hair cortisol analysis: an update on methodological considerations and clinical applications","volume":"63","author":"Greff","year":"2019","journal-title":"Clin Biochem."},{"issue":"4","key":"2022122606511267100_CIT0065","doi-asserted-by":"crossref","first-page":"M1","DOI":"10.1530\/EJE-15-0313","article-title":"Clinical applications of cortisol measurements in hair","volume":"173","author":"Wester","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2022122606511267100_CIT0066","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1530\/EJE-20-1127","article-title":"Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing\u2019s syndrome","volume":"184","author":"Brossaud","year":"2021","journal-title":"Eur J Endocrinol."},{"issue":"10","key":"2022122606511267100_CIT0067","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.2337\/db08-0495","article-title":"Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity","volume":"57","author":"Tomlinson","year":"2008","journal-title":"Diabetes."},{"issue":"2","key":"2022122606511267100_CIT0068","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0029-1220771","article-title":"Hair analysis provides a historical record of cortisol levels in Cushing\u2019s syndrome","volume":"118","author":"Thomson","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"5","key":"2022122606511267100_CIT0069","first-page":"297","article-title":"Spontaneous remission of unidentified Cushing\u2019s disease revealed by hair cortisol analysis","volume":"78","author":"van Boven","year":"2020","journal-title":"Neth J Med."},{"key":"2022122606511267100_CIT0070","first-page":"1","article-title":"Molecular derangements and the diagnosis of ACTH-dependent Cushing\u2019s syndrome","author":"Nieman","year":"2021","journal-title":"Endocr Rev."},{"issue":"3","key":"2022122606511267100_CIT0071","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1113\/jphysiol.2014.282871","article-title":"Cushing\u2019s syndrome: from physiological principles to diagnosis and clinical care","volume":"593","author":"Raff","year":"2015","journal-title":"J Physiol."},{"key":"2022122606511267100_CIT0072","article-title":"Adrenocortical carcinoma masquerading as Cushing\u2019s disease","volume":"bcr2016217519","author":"Jarial","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"2","key":"2022122606511267100_CIT0073","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3171\/2016.1.JNS152119","article-title":"Cushing\u2019s disease: pathobiology, diagnosis, and management","volume":"126","author":"Lonser","year":"2017","journal-title":"J Neurosurg."},{"issue":"11","key":"2022122606511267100_CIT0074","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111951","article-title":"Cushing\u2019s disease","volume":"8","author":"Nishioka","year":"2019","journal-title":"J Clin Med"},{"issue":"10","key":"2022122606511267100_CIT0075","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1210\/clinem\/dgaa409","article-title":"Non-invasive diagnostic strategy in ACTH-dependent Cushing\u2019s syndrome","volume":"105","author":"Frete","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022122606511267100_CIT0076","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s12020-021-02764-4","article-title":"Inferior petrosal sinus sampling in Cushing\u2019s syndrome: usefulness and pitfalls","volume":"73","author":"Vassiliadi","year":"2021","journal-title":"Endocrine"},{"issue":"5","key":"2022122606511267100_CIT0077","doi-asserted-by":"crossref","first-page":"e1953","DOI":"10.1210\/clinem\/dgab012","article-title":"Pitfalls in performing and interpreting inferior petrosal sinus sampling: personal experience and literature review","volume":"106","author":"Perlman","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022122606511267100_CIT0078","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1530\/EC-16-0029","article-title":"Bilateral inferior petrosal sinus sampling","volume":"5","author":"Zampetti","year":"2016","journal-title":"Endocr Connect"},{"issue":"7","key":"2022122606511267100_CIT0079","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00234-021-02886-6","article-title":"Does concomitant prolactin measurement increase the accuracy of inferior petrosal sinus sampling?","volume":"64","author":"Apaydin","year":"2022","journal-title":"Neuroradiology."},{"issue":"4","key":"2022122606511267100_CIT0080","doi-asserted-by":"crossref","first-page":"e1816","DOI":"10.1210\/clinem\/dgaa755","article-title":"Molecular imaging targeting corticotropin-releasing hormone receptor for corticotropinoma: a changing paradigm","volume":"106","author":"Walia","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022122606511267100_CIT0081","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/EJE-19-0877","article-title":"Management of endocrine disease: Cushing\u2019s syndrome due to ectopic ACTH secretion: an expert operational opinion","volume":"182","author":"Young","year":"2020","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2022122606511267100_CIT0082","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1507\/endocrj.K10E-389","article-title":"Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors","volume":"58","author":"Tani","year":"2011","journal-title":"Endocr J."},{"key":"2022122606511267100_CIT0083","doi-asserted-by":"crossref","first-page":"105856","DOI":"10.1016\/j.jsbmb.2021.105856","article-title":"Metabolic changes in serum steroids for diagnosing and subtyping Cushing\u2019s syndrome","volume":"210","author":"Ahn","year":"2021","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"2","key":"2022122606511267100_CIT0084","first-page":"440","article-title":"Diagnosis and management of Cushing\u2019s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis","volume":"84","author":"Invitti","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022122606511267100_CIT0085","doi-asserted-by":"crossref","first-page":"101386","DOI":"10.1016\/j.beem.2020.101386","article-title":"Adrenocortical hyperplasia: a multifaceted disease","volume":"34","author":"Bourdeau","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"1","key":"2022122606511267100_CIT0086","doi-asserted-by":"crossref","first-page":"101491","DOI":"10.1016\/j.beem.2021.101491","article-title":"Assessment of mild autonomous cortisol secretion among incidentally discovered adrenal masses","volume":"35","author":"Yozamp","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"11","key":"2022122606511267100_CIT0087","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the patient with adrenal incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022122606511267100_CIT0088","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"2022122606511267100_CIT0089","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40618-017-0644-8","article-title":"First-line screening tests for Cushing\u2019s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS\/MS","volume":"40","author":"Ceccato","year":"2017","journal-title":"J Endocrinol Invest."},{"issue":"6","key":"2022122606511267100_CIT0090","doi-asserted-by":"crossref","first-page":"R259","DOI":"10.1530\/EJE-17-1058","article-title":"Management of endocrine disease: management of Cushing\u2019s syndrome during pregnancy: solved and unsolved questions","volume":"178","author":"Brue","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022122606511267100_CIT0091","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/09513590.2014.984680","article-title":"Cushing\u2019s syndrome in pregnancy","volume":"31","author":"Nassi","year":"2015","journal-title":"Gynecol Endocrinol."},{"issue":"5","key":"2022122606511267100_CIT0092","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/jc.2004-2361","article-title":"Cushing\u2019s syndrome during pregnancy: personal experience and review of the literature","volume":"90","author":"Lindsay","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022122606511267100_CIT0093","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/01443615.2014.937331","article-title":"The diagnosis and management of Cushing syndrome during pregnancy","volume":"35","author":"Dong","year":"2015","journal-title":"J Obstet Gynaecol."},{"issue":"6","key":"2022122606511267100_CIT0094","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/cen.12853","article-title":"The morning and late-night salivary cortisol ranges for healthy women may be used in pregnancy","volume":"83","author":"Ambroziak","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2022122606511267100_CIT0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11102-015-0680-3","article-title":"Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing\u2019s disease","volume":"19","author":"Lopes","year":"2016","journal-title":"Pituitary"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac492\/45965720\/dgac492.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/11\/3162\/48413025\/dgac492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/11\/3162\/48413025\/dgac492.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T01:52:37Z","timestamp":1672019557000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/11\/3162\/6678587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":95,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,8,29]]},"published-print":{"date-parts":[[2022,11,23]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac492","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,8,29]]}}}